EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)

Ioannis G Lempesis, Vasiliki Epameinondas Georgakopoulou, Russel J Reiter, Demetrios A Spandidos

International Journal of Molecular Medicine · 2024

DOI: 10.3892/ijmm.2024.5352 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2024. Verfasst von Ioannis G Lempesis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, Melatonin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID‑19), a systemic illness caused by severe acute respiratory distress syndrome 2 (SARS‑CoV‑2), has triggered a worldwide pandemic with symptoms ranging from asymptomatic to chronic, affecting practically every organ. Melatonin, an ancient antioxidant found in all living organisms, has been suggested as a safe and effective therapeutic option for the treatment of SARS‑CoV‑2 infection due to its good safety characteristics and broad‑spectrum antiviral medication properties. Melatonin is essential in various metabolic pathways and governs physiological processes, such as the sleep‑wake cycle and circadian rhythms. It exhibits oncostatic, anti‑inflammatory, antioxidant and anti‑aging properties, exhibiting promise for use in the treatment of numerous disorders, including COVID‑19. The preventive and therapeutic effects of melatonin have been widely explored in a number of conditions and have been well‑established in experimental ischemia/reperfusion investigations, particularly in coronary heart disease and stroke. Clinical research evaluating the use of melatonin in COVID‑19 has shown various improved outcomes, including reduced hospitalization durations; however, the trials are small. Melatonin can alleviate mitochondrial dysfunction in COVID‑19, improve immune cell function and provide antioxidant properties. However, its therapeutic potential remains underexplored due to funding limitations and thus further investigations are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MelatoninHumansAntioxidantsPandemicsPost-Acute COVID-19 SyndromeSARS-CoV-2

Stichwörter der Autor:innen

COVID‑19antioxidantlong COVID‑19melatoninmitochondrial dysfunction

Substanzen

AntioxidantsMelatonin

Autor:innen und Institutionen

  • Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Cellular and Structural Biology, UT Health Science Center, San Antonio, TX 78229, USA.
  • Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Zitieren

APA

Lempesis, I. G., Georgakopoulou, V. E., Reiter, R. J., & Spandidos, D. A. (2024). A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2024.5352

Vancouver

Lempesis IG, Georgakopoulou VE, Reiter RJ, Spandidos DA. A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review). International Journal of Molecular Medicine. 2024. doi:10.3892/ijmm.2024.5352

BibTeX
@article{Lempesis2024,
  author = {Lempesis, Ioannis G and Georgakopoulou, Vasiliki Epameinondas and Reiter, Russel J and Spandidos, Demetrios A},
  title = {A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  doi = {10.3892/ijmm.2024.5352}
}
Kostenlos starten →